CAPSIDA
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.
CAPSIDA
Industry:
Biotechnology Genetics Health Care
Founded:
2019-01-01
Address:
Newbury Park, California, United States
Country:
United States
Website Url:
http://www.capsida.com
Total Employee:
11+
Status:
Active
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Color
Color is a complete platform for healthcare delivery.
Current Advisors List
Board_member
2021-01-01
Current Employees Featured
Robert M. Cuddihy Chief Executive Officer @ Capsida
Chief Executive Officer
Nicholas Flytzanis Co-founder and Chief Scientific Officer @ Capsida
Co-founder and Chief Scientific Officer
2021-11-01
Viviana Gradinaru Co-Founder @ Capsida
Co-Founder
2019-01-01
Nick Goeden Co-founder and Chief Technology Officer @ Capsida
Co-founder and Chief Technology Officer
2021-11-01
Bethany Mancilla Chief Business Officer @ Capsida
Chief Business Officer
2020-02-01
Founder
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Series A - Capsida
Versant Ventures
Versant Ventures investment in Series A - Capsida
AbbVie
AbbVie investment in Corporate Round - Capsida
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-07 | Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO |
Official Site Inspections
http://www.capsida.com
- Host name: 70.35.200.219
- IP address: 70.35.200.219
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Capsida"
Capsida - Crunchbase Company Profile & Funding
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.See details»
Capsida Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Capsida is a biotech firm that focuses on addressing genetic and sporadic CNS and non-CNS conditions. The company utilizes a unique AAV engineering platform to create capsids tailored …See details»
Capsida Company Profile: Overview and Full News Analysis
Dec 9, 2024 Capsida Biotherapeutics, located in California, is an industry-leading gene therapy platform company focused on engineering novel AAVs and developing the next generation of …See details»
Capsida - Overview, News & Similar companies | ZoomInfo.com
View Capsida (www.capsida.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Pipeline - Capsida Biotherapeutics
Capsida’s pipeline consists of next generation intravenously (IV) administered gene therapies. Capsida’s gene therapies utilize proprietary engineered capsids that enable high transduction …See details»
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics …
Oct 30, 2024 Wholly owned first-in-class program anticipated to enter clinical trials in first half of 2025 THOUSAND OAKS, Calif., October 30, 2024 – Capsida Biotherapeutics (“Capsida”) …See details»
Capsida Biotherapeutics, Inc. | MedPath
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy Withdrawn Conditions STXBP1 Encephalopathy with Epilepsy Subscribe First Posted Date 2022-07-18 …See details»
Capsida Biotherapeutics Headquarters and Office Locations
Capsida Biotherapeutics is headquartered in Thousand Oaks, 1290 Rancho Conejo Blvd, United States, and has 1 office location.See details»
Capsida Los Angeles - Crunchbase Company Profile & Funding
View contacts for Capsida Los Angeles to access new leads and connect with decision-makers.See details»
Capsida Signs Partnership to Develop Medicines
Jan 30, 2023 Capsida’s partnership deal announced on Jan. 4 is with Prevail Therapeutics, a wholly owned subsidiary of Indianapolis-based pharma giant Eli Lilly. Prevail’s focus is also on …See details»
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics …
Nov 1, 2024 Capsida Biotherapeutics announced this big news on PR Newswire this October 30, 2024. The STXBP1 Foundation is thrilled to share it with you. FDA Grants Orphan Drug …See details»
Capsida Biotherapeutics Announces Strategic Collaboration with …
Jan 4, 2023 Capsida is a multi-functional and fully integrated biotechnology company with proprietary adeno-associated virus (AAV) engineering, multi-modality cargo development and …See details»
Capsida Biotherapeutics granted orphan drug designation for …
Nov 3, 2024 Capsida Clinical Trial Information as of February 2025 Capsida Biotherapeutics, a biotech company, just announced that the US Food and Drug Administration (FDA) granted an …See details»
CAP-003 - Drug Targets, Indications, Patents - Synapse
CAP-003: a GBA modulators Drug, Initially developed by Capsida Biotherapeutics, Inc., Now, its global highest R&D status is Preclinical, Mechanism: GBA modulators (Beta …See details»
New Preclinical Data Demonstrate Potential of Capsida’s IV Gene …
Dec 6, 2024 Capsida Biotherapeutics is a fully integrated gene therapy company with a central nervous system (CNS) pipeline consisting of disease modifying and potentially curative …See details»
Capsida Biotherapeutics
January 2025 This presentation is made solely for informational purposes and contains forward-looking statements based on current expectations and assumptions. These statements are not …See details»
Capsida創新AAV基因療法攻難治癲癇 2025H1進臨床-環球生技月刊
Dec 10, 2024 美國時間7日，Capsida Biotherapeutics在美國癲癇學會年會 (American Epilepsy Society)中，公開其開發的基因療法CAP-002在難治型癲癇——發展性癲癇性腦病變 (DEE)之 …See details»
Capsida Biotherapeutics Reviews: What Is It Like to Work At …
What are the pros and cons of working at Capsida Biotherapeutics? According to reviews on Glassdoor, employees commonly mention the pros of working at Capsida Biotherapeutics to …See details»
Windsor-Essex Children's Aid Society laying off 26 staff ... - CBC.ca
1 day ago More than two dozen employees at the Windsor-Essex Children's Aid Society (WECAS) have been laid off, their union said Friday, as the organization faces a $10-million …See details»
Combinatorial engineering across multiple surface exposed
Here, we employed Capsida Biotherapeutics’ combinatorial engineering strategy to evolve novel AAV capsids that are simultaneously enriched in the CNS and de-enriched in the liver …See details»